Abstract
Telomerase is a ribonucleoprotein enzyme that extends telomere DNA located in the chromosomal termini. Telomerase is known to specifically express in cancer cells, and telomerase activity was found in more than 80 % of cancer patients. Therefore, telomerase may represent a promising cancer biomarker and therapeutic target. The telomerase repeat amplification protocol (TRAP) assay is a polymerase chain reaction (PCR)-based method to detect telomerase activity. In this assay, the telomerase substrate (TS) primer is elongated and its extended DNA is amplified by PCR. Telomerase activity is evaluated by a ladder of bands differing by 6 bp after gel electrophoresis of the PCR products. Recently, non-PCR-based methods to detect telomerase activity have been reported by many researchers. Electrochemical telomerase assay (ECTA), which was developed by Takenaka’s group, is a simple and rapid PCR-free method to detect telomerase activity. ECTA consists of a TS primer-immobilized electrode and ferrocenylnaphthalene diimide derivative as a tetraplex binder. Takenaka’s group compared the efficacy of ECTA and TRAP methods in detecting telomerase activity in oral cancer screening. Telomerase activity was observed in 90 % and 30 % of oral cancer tissues and exfoliative cells using the TRAP method, respectively, whereas the ECTA method detected telomerase activity in 90 % and 85 % of oral cancer tissues and exfoliative cells, respectively. These findings suggested that the ECTA method is useful for oral cancer screening because exfoliative cells can be easily obtained by scraping the inside of the mouth. Because telomerase activity is specific to cancer cells, ligands that inhibit telomerase activity may show promise as anticancer drugs. ECTA has also been used to estimate the inhibitory activity of telomerase ligands in cancer cells by determining TS primer elongation in a concentration-dependent manner. The ECTA method was used to screen for the telomerase inhibitory activity of 10 ligands and demonstrated not only the inhibitory activity of the ligands but also their mechanisms of action. The drugs having non-elongating capability directly inhibited telomerase. On the other hand, another set of drugs that can elongate at a 24-mer expansion indirectly inhibited telomerase access by binding and stabilizing the tetraplex structures.
Abbreviations
- Ca9-22:
-
Human Gingival Squamous Cell Carcinoma Cell Lines
- ECTA:
-
Electrochemical Telomerase Assay
- EtBr:
-
Ethidium Bromide
- FND:
-
Ferrocenylnaphthalene Diimide
- HSC-2:
-
Human Oral Squamous Cell Carcinoma Cell Lines
- HSC-3:
-
Human Tongue Squamous Cell Carcinoma Cell Lines
- hTERT:
-
Human Telomerase Reverse Transcriptase
- IC50 :
-
Half maximal (50 %) Inhibitory Concentration
- Inhibitor III:
-
Hexameric Phosphorothioate Oligonucleotide, 5′-d(TTAGGG)-3′
- Inhibitor V:
-
2,6-bis[3-(N-piperidino)propionamido]anthracene-9,10-dione
- PCR:
-
Polymerase Chain Reaction
- PIPER:
-
N,N′-bis [2-(1-piperidino)ethyl]-3,4,9,10-tetracarboxylic diimide
- Q:
-
Charge Quantity
- SAS:
-
Human Tongue Squamous Cell Carcinoma Cell Line
- SPR:
-
Surface Plasmon Resonance
- SWV:
-
Square Wave Voltammetry
- TBM:
-
3,3′,5,5′-Tetramethylbenzidine
- TER:
-
Telomerase RNA Component
- TERT:
-
Telomerase Reverse Transcriptase
- TMPyP4:
-
5,10,15,20-tetra-(N-methyl-4-pyridyl)porphine
- TND:
-
Tri Naphthalene Diimide
- TRAP:
-
Telomerase Repeat Amplification protocol
- TS:
-
Primer Telomerase Substrate Primer
References
Arion D, Kaushik N, McCormick S, et al. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry. 1998;37:15908–17.
Boon EM, Ceres DM, Drummond TG, et al. Mutation detection by electrocatalysis at DNA-modified electrodes. Nat Biotechnol. 2000;18:1096–100.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–9.
Cian AD, Cristofari G, Reichenbach P, et al. Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action. Proc Natl Acad Sci U S A. 2007;104:17347–52.
Cuenca F, Greciano O, Gunaratnam M, et al. Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands. Bioorg Med Chem Lett. 2008;18:1668–73.
Drummond TG, Hill MG, Barton JK. Electrochemical DNA sensors. Nat Biotechnol. 2003;21:1192–9.
Eskiocak U, Ozkan-Ariksoysal D, Ozsoz M, et al. Label-free detection of telomerase activity using guanine electrochemical oxidation signal. Anal Chem. 2007;79:8807–11.
Fedoroff OY, Salazar M, Han H, et al. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry. 1998;37:12367–74.
Freeman R, Sharon E, Teller C, Henning A, Tzfati Y, Willner I, et al. DNAzyme-like activity of hemin-telomeric G-quadruplexes for the optical analysis of telomerase and its inhibitors. Chembiochem. 2010;11:2362–7.
Fujimoto R, Kamata N, Yokoyama K, et al. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol. 2001;37:132–40.
Gillis AJ, Schuller AP, Skordalakes E. Structure of the tribolium castaneum telomerase catalytic subunit TERT. Nature. 2008;455:633–7.
Greider CW, Telomeres Do D-Loop-T-Loop. Cell. 1999;97:419–22.
Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985;43:405–13.
Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337:331–7.
Han FX, Wheelhouse RT, Hurley LH. Interactions of TMPyP4 and TMPyP2 with quadruplex DNA. Structural basis for the differential effects on telomerase inhibition. J Am Chem Soc. 1999;121:3562–9.
Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett. 2003;194:221–33.
Hukezalie KR, Wong JMY. Structure–function relationship and biogenesis regulation of the human telomerase holoenzyme. FEBS J. 2013;280:3194–204.
Jiang J, Miracco EJ, Hong K, Ecket B, et al. The architecture of Tetrahymena telomerase holoenzyme. Nature. 2013;496:187–92.
Kato D, Sekioka N, Ueda A, et al. A nanocarbon film electrode as a platform for exploring DNA methylation. J Am Chem Soc. 2008;130:3716–7.
Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–5.
Kulla E, Katz E. Biosensor techniques used for determination of telomerase activity in cancer cells. Sensors. 2008;8:347–69.
Luo X, Hsing IM. Electrochemical techniques on sequence-specific PCR amplicon detection for point-of-care applications. Analyst. 2009;134:1957–64.
Maesawa C, Inaba T, Sato H, et al. A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance. Nucleic Acids Res. 2003;31:E4–4.
Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Can Res Suppl. 1996;56:5600–4.
Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acid Res. 2002;30:839–65.
Miyahara H, Yamashita K, Kanai M, et al. Electrochemical analysis of single nucleotide polymorphisms of p53 gene. Talanta. 2002;56:829–35.
Mori K, Sato S, Kodama M, et al. Oral cancer diagnosis via a ferrocenylnaphthalene diimide-based electrochemical telomerase assay. Clin Chem. 2013;59:289–95.
Mutirangura A, Supiyaphun P, Trirekapan S, et al. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Can Res Suppl. 1996;56:3530–3.
Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41:181–90.
Pavlov V, Willner I, Dishon A, et al. Amplified detection of telomerase activity using electrochemical and quartz crystal microbalance measurements. Biosens Bioelectron. 2004;20:1011–21.
Perry PJ, Gowan SM, Reszka AP, et al. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J Med Chem. 1998;41:3253–60.
Quach QH, Jung J, Kim H, et al. A simple, fast and highly sensitive assay for the detection of telomerase activity. Chem Commun. 2013;49:6596–8.
Raichlin S, Sharon E, Freeman R, Tzfati Y, Willner I. Electron-transfer quenching of nucleic acid-functionalized CdSe/ZnS quantum dots by doxorubicin: a versatile system for the optical detection of DNA, aptamer-substrate complexes and telomerase activity. Biosens Bioelectron. 2011;26:4681–9.
Sanchini MA, Gunelli R, Nanni O, et al. Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA. 2005;294:2052–6.
Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A. 1997;94:4262–6.
Sato S, Takenaka S. Linker effect of ferrocenylnaphthalene diimide ligands in the interaction with double stranded DNA. J Organomet Chem. 2008;693:1177–85.
Sato S, Takenaka S. PCR-free telomerase assay using chronocoulometry coupled with hexaammineruthenium(III) chloride. Anal Chem. 2012;84:1772–5.
Sato S, Kondo H, Nojima T, et al. Electrochemical telomerase assay with ferrocenylnaphthalene diimide as a tetraplex DNA-specific binder. Anal Chem. 2005a;77:7304–9.
Sato S, Nojima T, Waki M, et al. Supramolecular complex formation by beta-cyclodextrin and ferrocenylnaphthalene diimide-intercalated double stranded DNA and improved electrochemical gene detection. Molecules. 2005b;10:693–707.
Sato S, Hokazono K, Irie T, et al. Ferrocenylnaphthalene diimide-based electrochemical detection of methylated gene. Anal Chim Acta. 2006;578:82–7.
Sato S, Tsueda M, Kanezaki Y, et al. Detection of an aberrant methylation of CDH4 gene in PCR product by ferrocenylnaphthalene diimide-based electrochemical hybridization assay. Anal Chim Acta. 2012;715:42–8.
Sauerwald A, Sandin S, Cristofari G, et al. Structure of active dimeric human telomerase. Nat Struct Mol Biol. 2013;20:454–61.
Steel AB, Herne TM, Tarlov MJ. Electrochemical quantitation of DNA immobilized on gold. Anal Chem. 1998;70:4670–7.
Takenaka S, Yamashita K, Takagi M, et al. DNA sensing on a DNA probe-modified electrode using ferrocenylnaphthalene diimide as the electrochemically active ligand. Anal Chem. 2000;72:1334–41.
Thongprasom K, Mutirangura A, Cheerat S. Telomerase activity in oral lichen planus. J Oral Pathol Med. 1998;27:395–8.
Tian T, Peng S, Xiao H, et al. Highly sensitive detection of telomerase based on a DNAzyme strategy. Chem Commun. 2013;49:2652–4.
Umek RM, Lin SW, Vielmetter J, et al. Electronic detection of nucleic acids: a versatile platform for molecular diagnostics. J Mol Diagn. 2001;3:74–84.
Wang Y, Patel DJ. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure. 1993;1:263–82.
Wang H, Donovan MJ, Meng L, et al. DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis. Chemistry. 2013;19:4633–9.
Weng J, Zhang J, Li H, et al. Label-free DNA sensor by boron-doped diamond electrode using an ac impedimetric approach. Anal Chem. 2008;80:7075–83.
Xiao Y, Lubin AA, Baker BR, et al. Single-step electronic detection of femtomolar DNA by target-induced strand displacement in an electrode-bound duplex. Proc Natl Acad Sci U S A. 2006;103:16677–80.
Xiao Y, Pavlov V, Gill R, Bourenko T, Willner I. Lighting up biochemiluminescence by the surface self-assembly of DNA-hemin complexes. Chem Bio Chem. 2004;5:374–9.
Xu Y, Noguchi Y, Sugiyama H. The new models of the human telomere d[AGGG(TTAGGG)3] in K+ solution. Bioorg Med Chem. 2006;14:5584–91.
Yang W, Zhu X, Liu Q, et al. Label-free detection of telomerase activity in HeLa cells using electrochemical impedance spectroscopy. Chem Commun. 2011;47:3129–31.
Yen SF, Gabbay EJ, Wilson WD. Interaction of aromatic imides with deoxyribonucleic acid. Spectrophotometric and viscometric studies. Biochemistry. 1982;21:2070–6.
Zheng G, Patolsky F, Cui Y, et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol. 2005;23:1294–301.
Zhong LP, Chen GF, Xu ZF, et al. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg. 2005;34:566–70.
Zhou X, Xing D. Assays for human telomerase activity: progress and prospects. Chem Soc Rev. 2012;41:4643–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Takenaka, S., Sato, S. (2015). Telomerase as Biomarker for Oral Cancer. In: Preedy, V., Patel, V. (eds) Biomarkers in Cancer. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7681-4_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-7681-4_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7680-7
Online ISBN: 978-94-007-7681-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences